Risk-Adapted, Ofatumumab-Based Chemoimmunotherapy and Maintenance in Treatment-Naïve CLL: A Phase II Study
- Resource Type
- Abstract
- Authors
- Desai, Sanjal; Drinkwater, Dennis ; Mo, Clifton Craig; Farooqui, Mohammed ZH ; Soto, Susan ; Valdez, Janet ; Gaglione, Erika M ; Tian, Xin ; Nierman, Pia ; Lotter, Jennifer ; Marti, Gerald ; Nichols, Cydney ; Taneja, Alankrita ; Herman, Sarah E.M. ; Maric, Irina; Wake, Laura M ; Stetler-Stevenson, Maryalice ; Yuan, Constance M. ; Hughes, Tom ; Lindorfer, Margaret A. ; Taylor, Ronald P. ; Wiestner, Adrian; Ahn, Inhye E
- Source
- In Blood 13 November 2019 134 Supplement 1:5474-5474
- Subject
- Language
- ISSN
- 0006-4971